2nd Quarter - Report
GOODWIN PROCTER LLP for TEVA PHARMACEUTICALS USA INC
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S.515, S.610, and H.R. 1260 (all entitled - A bill to amend title 35, United States Code, to provide for patent reform); (ALL PROVISIONS FOR ALL BILLS).
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELAINE BLAIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.